Pulmonary embolism (PE) is a life-threatening condition and a leading cause of morbidity
and mortality. There have been many advances in the field of PE in the last few years …

Pulmonary embolism (PE) is a major cause of morbidity and mortality in the United States.
Although new therapeutic tools and strategies have recently been developed for the …

Pulmonary embolism (PE) is a serious and prevalent cause of vascular disease.
Nevertheless, optimal treatment for many phenotypes of PE remains uncertain. Treating PE …

Objectives To evaluate the safety and efficacy of catheter‐directed thrombolysis (CDT) in the
treatment of acute pulmonary embolism (PE). Background The use of CDT for the treatment …

Background We provide the first multicenter analysis of patients cared for by eight
Pulmonary Embolism Response Teams (PERTs) in the United States (US); describing the …

Background Pulmonary embolism (PE) represents 2% to 5% of all causes of out-of-hospital
cardiac arrest (OHCA) and is associated with extremely unfavorable prognosis. In PE …

Background Transthoracic echocardiography (TTE) is often considered for risk stratification
of patients with acute pulmonary embolism (PE). We sought to determine the contemporary …

The clinical management of patients with acute pulmonary embolism is rapidly changing
over the years. The widening spectrum of clinical management strategies for these patients …

Purpose Syncope is an atypical presentation for acute pulmonary embolism (APE). There
are conflicting data concerning syncope and prognosis of APE. Patients and methods One …

Pulmonary embolism represents the third most common cause of cardiovascular death in
the United States. Reperfusion therapeutic strategies such as systemic thrombolysis …